Skip to main content

Lomustine 40mg capsules (Medac, UK)

Section 19A approved medicine
Lomustine 40mg capsules (Medac, UK)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Current
Medicines in short supply/unavailable
CEENU lomustine 40mg capsule bottle - ARTG 19249
Indication(s)

Lomustine may be used for the treatment of:

  1. Brain tumours (primary and secondary)
  2. Hodgkin's disease (as secondary therapy). Lomustine is used in addition to appropriate surgical and/or radiotherapeutic procedures or as a component of various chemotherapeutic regimens in the palliative treatment of primary and metastatic brain tumours. Lomustine containing combinations should be used as alternative therapy in the treatment of disseminated Hodgkin's disease in patients refractory to other established treatment regimens.
Additional information
**Please note: start date of this approval is 01 July 2024**
Images
Picture of Lomustine 40mg capsules carton

Help us improve the Therapeutic Goods Administration site